Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Iman Majd, MD, MS, EAMP / LAc
Dr. Iman Majd is the director of the Osher Clinic for Integrative Medicine at the  University of Washington and a member of the NCCAOM board of commissioners. Learn more at https://integrativehealth.org/iman_majd.